Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
Bouchardy
C
C
Verkooijen
H M
HM
Fioretta
G
G
Sappino
A P
AP
Vlastos
G
G
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015994:Incidence; D018200:Mixed Tumor, Mullerian / Q000139:chemically induced* / Q000453:epidemiology; D012042:Registries; D012307:Risk Factors; D013557:Switzerland / Q000453:epidemiology; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen